文献速递妇科产科

美国医师密度与妇科癌症结局的相关性

Association of Physician Densities and Gynecologic Cancer Outcomes in the United States.
PubMed 文献 · Obstet Gynecol · 2022-10-05

该回顾性队列研究利用SEER数据库2005至2018年数据,分析县级妇产科医师和基层医疗医师密度与妇科癌症结局的关联。结果显示基层医疗医师密度增加与宫颈癌诊断分期更早和5年生存率提高相关,而妇产科医师密度对子宫癌或卵巢癌的分期或生存结局无影响。

要点

  • 基层医疗医师密度增加与宫颈癌诊断分期更早及5年生存率提高相关。
  • 妇产科医师密度对子宫癌或卵巢癌的分期或生存结局无影响。
  • 县级社会人口学因素与所有癌症类型的结局相关。

核心结论

  • 基层医疗医师密度增加而非妇产科医师密度增加与宫颈癌诊断分期更早和5年生存率提高相关。
  • 县级社会人口学因素包括人口多样性、都市状态、教育程度和家庭收入也与所有癌症类型的结局相关。
  • 在低密度县针对基层医疗医师供应和教育可能改善宫颈癌的人群护理。

研究设计与样本

  • 回顾性队列研究,分析SEER数据库2005至2018年子宫癌、卵巢癌和宫颈癌患者。
  • 最终分析纳入113,938例患者用于诊断分期分析,98,573例用于5年生存分析。
  • 医师密度来自Area Health Resources File,采用后退逐步回归模型。

主要发现

  • 子宫癌、卵巢癌和宫颈癌分别占患者的60.0%、25.0%和15.0%。
  • 大多数县(57%)为非都市县,平均妇产科医师密度为每10万女性8名,平均基层医疗医师密度为每10万女性89名。
  • 多变量分析显示,基层医疗医师密度增加与宫颈癌诊断分期更早相关(95% CI -6.27至-0.05;P<.05),与宫颈癌5年生存率提高相关(95% CI 0.03-0.09;P<.05)。
  • 妇产科医师密度未发现影响子宫癌或卵巢癌的分期或生存结局。
  • 宫颈癌分析中,家庭收入中位数与分期负相关(P=.01),学士学位比例和都市状态与5年生存率正相关(P<.01);子宫癌分析中,黑人女性比例与分期正相关(P<.01),与5年生存率负相关(P<.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether there is an association between county-level obstetrician-gynecologist (ob-gyn) and primary care physician (PCP) densities and gynecologic cancer outcomes in the United States. METHODS: A retrospective cohort study of gynecologic cancers (uterine, ovarian, and cervical) in the Surveillance, Epidemiology, and End Results (SEER) database was performed from 2005 to 2018. County-level demographics were abstracted from the SEER database, population density from the United States Census Bureau, and physician density (ob-gyns and PCPs/100,000 females) from the Area Health Resources File. Backward stepwise regression models were used. RESULTS: Final analysis included 113,938 patients for stage at diagnosis analysis and 98,573 patients for 5-year survival analysis. Uterine, ovarian, and cervical cancers represented 60.0%, 25.0%, and 15.0% of patients, respectively. Most counties (57%) were nonmetropolitan and had a mean ob-gyn density of 8 per 100,000 females and a mean PCP density of 89 per 100,000 females. Multivariate analysis showed that increasing PCP density was associated with earlier stage at diagnosis (95% CI -6.27 to -0.05; P <.05) and increased 5-year survival rates in cervical cancer (95% CI 0.03-0.09; P <.05). Obstetrician-gynecologist density was not found to affect stage or survival outcomes for uterine or ovarian cancer. Analysis of sociodemographic factors for cervical cancer showed that median household income was negatively correlated with stage ( P =.01) and that the percentage of those with bachelor's degrees and metropolitan status were positively correlated with 5-year survival rates ( P <.01). For uterine cancer, the percentage of Black females was positively correlated with stage ( P <.01) and negatively correlated with 5-year survival rates ( P <.01). CONCLUSION: Increasing PCP density, but not ob-gyn density, is associated with earlier stage at diagnosis and improved 5-year survival rates in cervical cancer. County-level sociodemographic factors, including population diversity, metropolitan status, educational attainment, and household income, were also correlated with outcomes across all cancer types. Targeting PCP supply and education in lower density counties may improve population-based care for cervical cancer.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Smick AH, Holbert M, Neff R, et al. Association of Physician Densities and Gynecologic Cancer Outcomes in the United States. Obstet Gynecol. 2022. PMID: 36201771. doi:10.1097/AOG.0000000000004955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。